Expressions of Survivin and Its Variants Mrna in Bladder Transitional Cell Carcinoma

燕翔,丁强,张元芳,徐永华,郭宏骞,孙则禹

DOI: https://doi.org/10.3969/j.issn.0253-3685.2007.06.008

2007-01-01

Abstract:Objective To investigate the expressions of survivin and its variants in bladder transitional cell carcinoma and the relationship between the expression and the stage or grade of bladder cancer. Methods Of 30 patients with bladder transitional cell carcinoma,17 cases were at stage of T_a or T_1, 13 cases T_2～T_4. Twenty three cases were in degree of G_1/ G_2 and 7 cases G_3. Eight cases had the matched pairs of non-neoplastic tissue samples. Eight samples of normal bladder mucosa were from non-tumor cases. Total RNA was extracted from bladder cancer tissues according to the TRIzol protocol. cDNA was synthesized from total RNA of each sample,and cDNA was used for PCR. Glyceraldehyde phosphate dehydrogenase(GAPDH) was also amplified as an internal control. The PCR bands were analyzed by BIO-RAD Quantity One 4.5 software. Results In 28 cases of 30 tumor tissue samples, the expressions of survivin and its variants were detected. Survivin was the predominant transcript variant, whereas only low level of survivin-Ex3 and survivin-2B were observed. The differences of expression between the survivin variants were statistically significant(P0.01).In contrast, a significant decrease in the expression of the non-anti-apoptotic survivin-2B variant became evident at advanced stages or grades of bladder cancer(P0.01).Conclusion We have found the variants of survivin in bladder cancer, and demonstrated that the expression of survivin-2B at high stage or grade bladder cancer is down-regulated,indicating that its antiapoptotic function may be lower than other variants.